• New drug hope for rare bone cancer patients worldpharmanews
    October 13, 2017
    In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors.
  • China accelerates new drug approvals biospectrumasia
    October 10, 2017
    The move is also a growth opportunity for international and local drugmakers in the world’s second biggest pharmaceutical market.
PharmaSources Customer Service